We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Analytical Cannabis Logo
Home > Resources > Industry Releases > Content Piece

Pressure BioSciences Doubles Growth Projections For Nano-emulsion Contracts

Published: Aug 08, 2022   
Listen with
Register for FREE to listen to this article
Thank you. Listen to this article using the player above.

Pressure BioSciences, Inc., a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and specialty testing services to the worldwide biopharmaceuticals, nutraceuticals, cosmetics, agrochem, and food/beverage industries, today announced that its participation at the recent San Francisco and Chicago Cannabis Drinks Expos produced over 60 strong leads for prospective contracts serving the cannabis beverages sector. 

The need for more effective delivery of cannabis dosing quickly and with reliably repeatable precision was a nearly universal theme reinforced across two days of meetings with companies already active in or entering the $2 billion cannabis beverage market. Among these leads, seven companies requested immediate discussions and follow-up on the potential for incorporating PBI’s patented Ultra Shear Technology (UST) platform for the nano-emulsification of CBD and other cannabinoids into their cannabis product lines as quickly as possible.

Mr. Kenneth F. Micciche, PBI’s director of business development, commented: 

“PBI’s patented UST platform is a unique breakthrough nano-emulsification system designed to resolve one of the most significant problems facing manufacturers of cannabis infused beverages today: the extremely poor solubility of cannabis-derived oils (e.g., CBD) in water. Poor water solubility results in poor bioavailability of the oil-based cannabinoid (CBD, CBG, CBN, THC, etc.), results in unreliable and variable dosing and response times, and deprives the consumer of the ability to enjoy the full benefits of the cannabis active ingredients for which they are paying.”

As with any oil-based product, it is difficult for the water-based biochemistry of humans and other animals to access and absorb active ingredients hidden within oil droplets at the scale delivered by many current “nano-emulsion” technologies. The natural immiscibility of oil and water inhibits effective water solubility and absorption of oil-based components, resulting in poor and unpredictable bioavailability of active ingredients. 

This makes it exceedingly difficult to design and deliver proper dosing of the desired active ingredients. Scientific data have repeatedly shown that oil-based active ingredients manufactured into high quality nano-emulsions with consistent, low nano-droplet sizes have produced dramatically faster and reliably complete amounts of cannabinoids (and other oil-based active components). This revolution in absorption and bioavailability delivers higher quality and more desirable finished products for the consumer.

Mr. John B. Hollister, director of sales and marketing at PBI, reflected on PBI’s participation in these two cannabis drinks expositions: 

“With our proven ability to deliver what we believe to be the highest quality nano-emulsions of CBD and other cannabinoids worldwide, we had expected very positive meetings and engagement around UST. Frankly, these two expos vastly exceeded our expectations. The interest in our UST nano-emulsions platform kicked off with inquiries before the exhibits were even open and continued strong throughout each day and into the evening’s activities. We had dozens of visitors to our booth, comprised of a wide variety of beverage manufacturers - including producers of beer, seltzers, soft drinks, juices, energy drinks, and water. Although these visitors were from various parts of the beverage industry, they all had one thing in common – they needed a reliable method to provide fast and accurate dosing of CBD and other cannabinoids for infusion into their drinks.”

Mr. Hollister continued: “We identified over 60 booth visitors as highly qualified leads. Some were groups doing substantial business who quickly understood the benefits of the UST process; others were companies about to initiate production; still others were well-funded start-ups. Of these many leads, seven pressed strongly for immediate follow-up, including three who proposed working towards setting up UST nano-emulsion processing for cannabinoids in their own laboratories in 2023.”

Mr. Richard T. Schumacher, president and CEO of PBI, summed up: 

“This was our first time participating in cannabis-focused expositions – and it was a resounding success! Last month we announced our plan and forecast to have a minimum of six UST nano-emulsion toll-processing contracts in place by the close of 2022. Based on the immediate traction gained in these two cannabis beverage meetings, and the feedback to date from our Consortium colleagues at the Ohio State University focusing on UST introductions and rapid penetration into the Food and Beverages industry, we have increased our guidance to a total of twelve UST contracts to be closed by the end of 2022. We believe that each of these new contracts will offer $1M or more per year in incremental revenue to PBI in 2023 and beyond.”

This article has been republished from material provided by Pressure Biosciences. Note: material may have been edited for length and content. For further information, please contact the cited source.


Stay connected with the latest news in cannabis extraction, science and testing

Get the latest news with the FREE weekly Analytical Cannabis newsletter